Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Queensland Health
UBS
Chinese Patent Office
Citi
Argus Health
Baxter
Fish and Richardson
Boehringer Ingelheim

Generated: May 23, 2018

DrugPatentWatch Database Preview

Nexgen Pharma Company Profile

« Back to Dashboard

What is the competitive landscape for NEXGEN PHARMA, and what generic and branded alternatives to NEXGEN PHARMA drugs are available?

NEXGEN PHARMA has twenty-one approved drugs.



Summary for Nexgen Pharma
US Patents:0
Tradenames:19
Ingredients:19
NDAs:21

Drugs and US Patents for Nexgen Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Nexgen Pharma Inc PROPOXYPHENE HYDROCHLORIDE propoxyphene hydrochloride CAPSULE;ORAL 083185-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Nexgen Pharma BUTALBITAL AND ACETAMINOPHEN acetaminophen; butalbital TABLET;ORAL 090956-001 Aug 23, 2011 AA RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial
Nexgen Pharma Inc MEPROBAMATE meprobamate TABLET;ORAL 084220-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Nexgen Pharma Inc BROMPHENIRAMINE MALEATE brompheniramine maleate TABLET;ORAL 086187-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
McKesson
Medtronic
Johnson and Johnson
Fish and Richardson
Cerilliant
Federal Trade Commission
Cipla
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.